Home World Stellantis Italy Production Set to Rebound After Two-Year Decline
WorldBusiness

Stellantis Italy Production Set to Rebound After Two-Year Decline

Share
Stellantis Italy Production Set to Rebound After Two-Year Decline
Share

Stellantis is expected to produce about 450,000 vehicles in Italy this year, marking a recovery from two years of falling output, although production is still below the company’s earlier expectations.

The automaker assembled 340,745 vehicles in Italy during the first nine months of 2026, up 28% from the same period last year, according to a quarterly report by the FIM Cisl union. Car production rose 36.7%, while commercial vehicle output increased 17.3%.

The recovery has been supported by new models, including the Jeep Compass and hybrid Fiat 500, alongside continued production of the Fiat Panda. Further launches, including the DS7 and Lancia Gamma, are expected to contribute to output during the final months of the year.

However, the recovery has not been without setbacks. Production of the hybrid Fiat 500 is now expected to reach about 60,000 units this year, well below the original target of 100,000. Production stoppages caused by shortages of engine components and weaker demand have affected the model.

Last year, Stellantis produced just under 380,000 vehicles in Italy, including 213,706 passenger cars, its lowest annual production level in the country since 1954.

The expected 2026 rebound signals an improvement in the company’s Italian operations, but production remains well below the long-term target of one million vehicles a year.

See also  FG plans support for Aba textile cluster, agriculture
Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

Digital Payment Use Rises Among Nigerians Despite Fraud Experiences, Report Reveals

The 2026 State of Inclusive Instant Payment Systems in Africa (SIIPS) report,...

Banking Sell-Off Drags NGX Down as Investors Lose N406 Billion

Investors in Nigeria's stock market lost N406.34 billion in market value on...

African Businesses Face Shutdowns, Liquidation and Licence Revocations in Third Quarter of 2026

Several businesses across Africa faced shutdowns, insolvency proceedings and regulatory action in...

New pancreatic cancer pill raises hope as tumours disappear in early trials

A new daily pill, daraxonrasib, has shown promising results in early clinical...